Xie Y, Zhao R, Zheng Y, Li Y, Wu F, Lei Y
Oncogene. 2025; .
PMID: 40082556
DOI: 10.1038/s41388-025-03340-0.
Ma Q, Lu X, Tian W, Chen Y, He X
Heliyon. 2024; 10(13):e33904.
PMID: 39027542
PMC: 11255569.
DOI: 10.1016/j.heliyon.2024.e33904.
Dai H, Yang X, Sheng X, Wang Y, Zhang S, Zhang X
Int J Biol Sci. 2023; 19(16):5319-5336.
PMID: 37928256
PMC: 10620816.
DOI: 10.7150/ijbs.85006.
Newell S, van der Watt P, Leaner V
IUBMB Life. 2023; 76(1):4-25.
PMID: 37623925
PMC: 10952567.
DOI: 10.1002/iub.2773.
Jiang L, Li D, Wang C, Liao J, Liu J, Wei Q
Pathol Oncol Res. 2022; 28:1610518.
PMID: 35991835
PMC: 9385962.
DOI: 10.3389/pore.2022.1610518.
Inhibition of Karyopherin β1-Mediated Nuclear Import Disrupts Oncogenic Lineage-Defining Transcription Factor Activity in Small Cell Lung Cancer.
Kelenis D, Rodarte K, Kollipara R, Pozo K, Pal Choudhuri S, Spainhower K
Cancer Res. 2022; 82(17):3058-3073.
PMID: 35748745
PMC: 9444950.
DOI: 10.1158/0008-5472.CAN-21-3713.
Verdinexor, a Selective Inhibitor of Nuclear Exportin 1, Inhibits the Proliferation and Migration of Esophageal Cancer via XPO1/c-Myc/FOSL1 Axis.
Ou L, Wang X, Cheng S, Zhang M, Cui R, Hu C
Int J Biol Sci. 2022; 18(1):276-291.
PMID: 34975332
PMC: 8692140.
DOI: 10.7150/ijbs.66612.
Inhibition of Kpnβ1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer.
Chi R, van der Watt P, Wei W, Birrer M, Leaner V
BMC Cancer. 2021; 21(1):106.
PMID: 33530952
PMC: 7852134.
DOI: 10.1186/s12885-021-07819-3.
The nuclear export protein XPO1 - from biology to targeted therapy.
Azmi A, Uddin M, Mohammad R
Nat Rev Clin Oncol. 2020; 18(3):152-169.
PMID: 33173198
DOI: 10.1038/s41571-020-00442-4.
Importin β1 regulates cell growth and survival during adult T cell leukemia/lymphoma therapy.
Ishikawa C, Senba M, Mori N
Invest New Drugs. 2020; 39(2):317-329.
PMID: 32959166
DOI: 10.1007/s10637-020-01007-z.
Inhibiting Importin 4-mediated nuclear import of CEBPD enhances chemosensitivity by repression of PRKDC-driven DNA damage repair in cervical cancer.
Zhou Y, Liu F, Xu Q, Yang B, Li X, Jiang S
Oncogene. 2020; 39(34):5633-5648.
PMID: 32661323
PMC: 7441007.
DOI: 10.1038/s41388-020-1384-3.
IPO5 promotes the proliferation and tumourigenicity of colorectal cancer cells by mediating RASAL2 nuclear transportation.
Zhang W, Lu Y, Li X, Zhang J, Lin W, Zhang W
J Exp Clin Cancer Res. 2019; 38(1):296.
PMID: 31288861
PMC: 6617704.
DOI: 10.1186/s13046-019-1290-0.
Inhibition of Karyopherin beta 1 suppresses prostate cancer growth.
Yang J, Guo Y, Lu C, Zhang R, Wang Y, Luo L
Oncogene. 2019; 38(24):4700-4714.
PMID: 30742095
PMC: 6565446.
DOI: 10.1038/s41388-019-0745-2.
Controlling the Gatekeeper: Therapeutic Targeting of Nuclear Transport.
Kosyna F, Depping R
Cells. 2018; 7(11).
PMID: 30469340
PMC: 6262578.
DOI: 10.3390/cells7110221.
A tight balance of Karyopherin β1 expression is required in cervical cancer cells.
Carden S, van der Watt P, Chi A, Ajayi-Smith A, Hadley K, Leaner V
BMC Cancer. 2018; 18(1):1123.
PMID: 30445944
PMC: 6240311.
DOI: 10.1186/s12885-018-5044-8.
KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells.
Zhu Z, Liu J, Li K, Zheng J, Xiong Z
Oncogene. 2018; 37(22):2936-2952.
PMID: 29520102
PMC: 5978811.
DOI: 10.1038/s41388-018-0180-9.
Ten hub genes associated with progression and prognosis of pancreatic carcinoma identified by co-expression analysis.
Zhou Z, Cheng Y, Jiang Y, Liu S, Zhang M, Liu J
Int J Biol Sci. 2018; 14(2):124-136.
PMID: 29483831
PMC: 5821034.
DOI: 10.7150/ijbs.22619.
Suppression of Kpnβ1 expression inhibits human breast cancer cell proliferation by abrogating nuclear transport of Her2.
Sheng C, Qiu J, He Z, Wang H, Wang Q, Guo Z
Oncol Rep. 2017; 39(2):554-564.
PMID: 29251332
PMC: 5783623.
DOI: 10.3892/or.2017.6151.
Decreased KPNB1 Expression is Induced by PLK1 Inhibition and Leads to Apoptosis in Lung Adenocarcinoma.
Sekimoto N, Suzuki Y, Sugano S
J Cancer. 2017; 8(19):4125-4140.
PMID: 29187890
PMC: 5706017.
DOI: 10.7150/jca.21802.
KPNB1-mediated nuclear import is required for motility and inflammatory transcription factor activity in cervical cancer cells.
Stelma T, Leaner V
Oncotarget. 2017; 8(20):32833-32847.
PMID: 28427184
PMC: 5464831.
DOI: 10.18632/oncotarget.15834.